Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital.

MLA

Mendes, Diogo, et al. “Real-World Intensive Safety Monitoring of Biosimilars Rituximab and Trastuzumab in a Portuguese Oncology Hospital.” Journal of Oncology Pharmacy Practice, vol. 27, no. 6, Aug. 2021, pp. 1432–38. EBSCOhost, https://doi.org/10.1177/1078155220957079.

APA

Mendes, D., Abrantes, J., Rigueiro, G., Pais, A. F., Penedones, A., Alves, C., & Batel-Marques, F. (2021). Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital. Journal of Oncology Pharmacy Practice, 27(6), 1432–1438. https://doi.org/10.1177/1078155220957079

Chicago

Mendes, Diogo, Joana Abrantes, Graça Rigueiro, Ana Filipa Pais, Ana Penedones, Carlos Alves, and Francisco Batel-Marques. 2021. “Real-World Intensive Safety Monitoring of Biosimilars Rituximab and Trastuzumab in a Portuguese Oncology Hospital.” Journal of Oncology Pharmacy Practice 27 (6): 1432–38. doi:10.1177/1078155220957079.